Inhibikase Therapeutics, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2020 | 595.74x | $0.00 | $2.59 |
| Dec 2021 | 71.56x | $0.01 | $0.55 |
| Dec 2022 | 102.64x | $0.00 | $0.19 |
| Dec 2023 | 29.39x | $0.00 | $0.08 |
| Sep 2024 | 115,473,410.00x | $0.00 | $0.81 |